Vodafone Greece targets consumers with 3G femtocell service

Commercial 3G femtocell services have been launched by Vodafone Greece aimed at improving residential or SoHo coverage. The launch means Vodafone now has commercial femtocell services in Qatar, Spain and the UK, with Vodafone Greece now joining the UK in targeting the consumer and small office segment.

The company said that the Huawei-manufactured femtocell would be provided free or with a discount to post-paid subscribers. Prepay users or post-paid subscribers that were not eligible for a discount would be charged €150 for the unit.

This pricing could make the Vodafone femtocell unattractive to consumers, as was seen when UK consumers were faced with this level of pricing. The company soon dropped this by around 70 per cent (albeit heavily subsidised), which proved key to attracting consumers to the service.

Unfortunately, the company seems not to have learned from its early experiences with UK consumers, and has also adopted the clunky ‘Vodafone Access Gateway' brand instead of the more easily understood 'Sure Signal' brand name now used in the UK.

Some industry observers have been tempted to comment that Vodafone, which is the leading femtocell pioneer in Europe, is still experimenting with consumer pricing models together with femtocells' role for enterprise and metro use. Its Spanish service is exclusively for enterprise use, while its Qatar femtocells are providing metro coverage.

For more on this story:
- read Mobile Europe

Related stories
Vodafone slashes femtocell price by 70%
Vodafone Spain targets enterprise users with femtocell launch
Vodafone's femto service goes intermittent
Gaining subscribers, reducing churn; the femtocell niche

Suggested Articles

Wireless operators can provide 5G services with spectrum bands both above and below 6 GHz—but that doesn't mean that all countries will let them.

Here are the stories we’re tracking today.

The 5G Mobile Network Architecture research project will implement two 5G use cases in real-world test beds.